Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,292 | -10,649 | -5,734 | -4,260 | -2,223 |
| Depreciation Amortization | 17 | -53 | 15 | 4 | 2 |
| Accounts receivable | 483 | -43 | -700 | -27 | -42 |
| Other Working Capital | 1,195 | 387 | -636 | -44 | -919 |
| Other Operating Activity | 1,412 | 1,256 | 1,359 | 427 | 159 |
| Operating Cash Flow | $-9,185 | $-9,102 | $-5,696 | $-3,900 | $-3,023 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,103 | -3,919 | N/A | N/A | N/A |
| PPE Investments | -31 | 11 | -50 | -22 | -7 |
| Investing Cash Flow | $-16,134 | $-3,908 | $-50 | $-22 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -5 | N/A | N/A | N/A |
| Common Stock Issued | 28,850 | 75 | 21,216 | 3,539 | 4,593 |
| Financing Cash Flow | $28,845 | $70 | $21,216 | $3,539 | $4,593 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 8 |
| Beginning Cash Position | 3,883 | 16,823 | 1,353 | 1,736 | 166 |
| End Cash Position | 7,409 | 3,883 | 16,823 | 1,353 | 1,736 |
| Net Cash Flow | $3,526 | $-12,940 | $15,470 | $-383 | $1,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,185 | -9,102 | -5,696 | -3,900 | -3,023 |
| Capital Expenditure | -47 | -2 | -50 | -22 | -7 |
| Free Cash Flow | -9,232 | -9,104 | -5,746 | -3,922 | -3,030 |